Clinical Trial Detail

NCT ID NCT00954174
Title Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritorium Cavity Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements no
Sponsors Gynecologic Oncology Group
Indications

peritoneal carcinoma

ovarian carcinosarcoma

uterine corpus sarcoma

Therapies

Carboplatin + Paclitaxel

Ifosfamide + Paclitaxel

Age Groups: adult

No variant requirements are available.